Copyright ©2023 SMART CAMP
SMART CAMP
Critical Analytics for Manufacturing Personalised-medicine
Cell therapy is an emerging medical product. Imagine the power of providing only the best cells to each patient, because you can quantify and control what "best" means for each cell product.
Why CAMP?
Critical Analytics for Manufacturing Personalized-medicine, or SMART CAMP, is an Interdisciplinary Research Group in Singapore and at MIT focusing on better ways to produce living cells as medicine delivered to humans.
CAMP was launched in June 2019, with the goal to address two key bottlenecks facing production of a range of potential cell therapies: Critical Quality Attributes (CQA) and Process Analytic Technologies (PAT) for cell therapy production.
Leveraging on several promising results and outcomes, CAMP starts its Phase-2 in Dec-2024/Jan-2025 with the focus on
T-Cells
&
hiPSC
for Cell Therapy manufacturing and Applications in collaboration with Singapore Researchers.
CAMP is part of a wider national effort on cell therapy manufacturing in Singapore.
CAMP invents and demonstrate these CQA/PAT capabilities:
From stem to immune cells
Addressing ailments ranging from cancer to damaged or aging tissues
Targeting adherent and suspended cells, with and without genetic engineering
For Scalable Manufacturing
Our goal is that this applied research and the new workforce that develops with and for the manufacturing industry & clinics will provide patients with enhanced access to promising, approved therapies.
The Singapore National Research Foundation supports this multi-million, multi-year project convening MIT and Singapore investigators and talented researchers from engineering, science, and clinical backgrounds.
Find out more about CAMP
research areas